Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 651

1.

Adenoid Cystic Carcinoma of the Breast: A Case Report.

Kashiwagi S, Asano Y, Ishihara S, Morisaki T, Takashima T, Tanaka S, Amano R, Ohsawa M, Hirakawa K, Ohira M.

Case Rep Oncol. 2019 Sep 17;12(3):698-703. doi: 10.1159/000502949. eCollection 2019 Sep-Dec.

2.

Gut microbiota differences in elderly subjects between rural city Kyotango and urban city Kyoto: an age-gender-matched study.

Naito Y, Takagi T, Inoue R, Kashiwagi S, Mizushima K, Tsuchiya S, Itoh Y, Okuda K, Tsujimoto Y, Adachi A, Maruyama N, Oda Y, Matoba S.

J Clin Biochem Nutr. 2019 Sep;65(2):125-131. doi: 10.3164/jcbn.19-26. Epub 2019 Aug 9.

3.

Clinical Evaluation of Dynamic Monitoring of Neutrophil-to-lymphocyte and Platelet-to-lymphocyte Ratios in Primary Endocrine Therapy for Advanced Breast Cancer.

Takada K, Kashiwagi S, Asano Y, Goto W, Takahashi K, Shibutani M, Amano R, Takashima T, Tomita S, Hirakawa K, Ohira M.

Anticancer Res. 2019 Oct;39(10):5581-5588. doi: 10.21873/anticanres.13752.

PMID:
31570453
4.

Sorafenib inhibits vascular endothelial cell proliferation stimulated by anaplastic thyroid cancer cells regardless of BRAF mutation status.

Ishihara S, Onoda N, Noda S, Asano Y, Tauchi Y, Morisaki T, Kashiwagi S, Takashima T, Ohira M.

Int J Oncol. 2019 Sep 19. doi: 10.3892/ijo.2019.4881. [Epub ahead of print]

5.

Continuous intraoperative neuromonitoring for thyroid cancer surgery: A prospective study.

Onoda N, Noda S, Tauchi Y, Asano Y, Kusunoki Y, Ishihara S, Morisaki T, Kashiwagi S, Takashima T, Ohira M.

Laryngoscope Investig Otolaryngol. 2019 Jul 18;4(4):455-459. doi: 10.1002/lio2.290. eCollection 2019 Aug.

6.

Pure Mucinous Breast Carcinoma with Micropapillary Pattern (MUMPC): A Case Report.

Asano Y, Kashiwagi S, Nagamori M, Tanaka S, Kuwae Y, Amano R, Takashima T, Ohsawa M, Hirakawa K, Ohira M.

Case Rep Oncol. 2019 Jul 16;12(2):554-559. doi: 10.1159/000501766. eCollection 2019 May-Aug.

7.

International review of national-level guidelines on end-of-life care with focus on the withholding and withdrawing of artificial nutrition and hydration.

Mayers T, Kashiwagi S, Mathis BJ, Kawabe M, Gallagher J, Morales Aliaga ML, Kai I, Tamiya N.

Geriatr Gerontol Int. 2019 Sep;19(9):847-853. doi: 10.1111/ggi.13741. Epub 2019 Aug 6.

PMID:
31389113
8.

The Effects of Eribulin on Breast Cancer Microenvironment Identified Using Eribulin-resistant Breast Cancer Cell Lines.

Goto W, Kashiwagi S, Asano Y, Takada K, Takahashi K, Fujita H, Takashima T, Shibutani M, Amano R, Tomita S, Hirakawa K, Ohira M.

Anticancer Res. 2019 Aug;39(8):4031-4041. doi: 10.21873/anticanres.13559.

PMID:
31366485
9.

Dual-Channel Fluorescence Imaging of Hydrogel Degradation and Tissue Regeneration in the Brain.

Park GK, Kim SH, Kim K, Das P, Kim BG, Kashiwagi S, Choi HS, Hwang NS.

Theranostics. 2019 May 31;9(15):4255-4264. doi: 10.7150/thno.35606. eCollection 2019.

10.

Verification of the effects of calcium channel blockers on the immune microenvironment of breast cancer.

Takada K, Kashiwagi S, Asano Y, Goto W, Takahashi K, Fujita H, Takashima T, Tomita S, Hirakawa K, Ohira M.

BMC Cancer. 2019 Jun 24;19(1):615. doi: 10.1186/s12885-019-5828-5.

11.

Prognostic Value of Quality of Life in Endocrine Therapy for Elderly Patients With Breast Cancer: A Retrospective Study.

Takada K, Kashiwagi S, Asano Y, Goto W, Takahashi K, Shibutani M, Amano R, Takashima T, Tomita S, Hirakawa K, Ohira M.

Anticancer Res. 2019 Jun;39(6):2941-2950. doi: 10.21873/anticanres.13424.

PMID:
31177133
12.

Real-Time Imaging of Vaccine Biodistribution Using Zwitterionic NIR Nanoparticles.

Katagiri W, Lee JH, Tétrault MA, Kang H, Jeong S, Evans CL, Yokomizo S, Santos S, Jones C, Hu S, Fakhri GE, Tsukada K, Choi HS, Kashiwagi S.

Adv Healthc Mater. 2019 Aug;8(15):e1900035. doi: 10.1002/adhm.201900035. Epub 2019 Jun 5.

PMID:
31165556
13.

In vitro neuraminidase inhibitory concentration (IC50) of four neuraminidase inhibitors in the Japanese 2017-18 season: Comparison with the 2010-11 to 2016-17 seasons.

Ikematsu H, Kawai N, Chong Y, Bando T, Iwaki N, Kashiwagi S.

J Infect Chemother. 2019 Aug;25(8):649-652. doi: 10.1016/j.jiac.2019.04.007. Epub 2019 May 14.

PMID:
31101530
14.

Clinical Outcomes of Recombinant Human-soluble Thrombomodulin Treatment for Disseminated Intravascular Coagulation in Solid Tumors.

Kashiwagi S, Asano Y, Takahashi K, Shibutani M, Amano R, Tomita S, Hirakawa K, Ohira M.

Anticancer Res. 2019 May;39(5):2259-2264. doi: 10.21873/anticanres.13342. Review.

PMID:
31092417
15.

De-escalated neoadjuvant therapy with nanoparticle albumin-bound paclitaxel and trastuzumab for low-risk pure HER2 breast cancer.

Tanaka S, Matsunami N, Morishima H, Oda N, Takashima T, Noda S, Kashiwagi S, Tauchi Y, Asano Y, Kimura K, Fujioka H, Terasawa R, Kawaguchi K, Ikari A, Morimoto T, Michishita S, Kobayashi T, Sakane J, Nitta T, Sato N, Hokimoto N, Nishida Y, Iwamoto M.

Cancer Chemother Pharmacol. 2019 Jun;83(6):1099-1104. doi: 10.1007/s00280-019-03836-z. Epub 2019 Apr 8.

PMID:
30963212
16.

Neoadjuvant Chemotherapy With Nab-paclitaxel Plus Trastuzumab Followed by 5-Fluorouracil/Epirubicin/Cyclophosphamide for HER2-positive Operable Breast Cancer: A Multicenter Phase II Trial.

Tokunaga S, Takashima T, Kashiwagi S, Noda S, Kawajiri H, Tokumoto M, Nishimura S, Nishimori T, Ikeda K, Ogawa Y, Mizuyama Y, Sunami T, Tezuka K, Yamagata S, Ishikawa T, Kudoh S, Takada M, Hirakawa K, Ohira M.

Anticancer Res. 2019 Apr;39(4):2053-2059. doi: 10.21873/anticanres.13316.

PMID:
30952749
17.

A Peptide Derived from Phosphoinositide 3-kinase Inhibits Endocytosis and Influenza Virus Infection.

Fujioka Y, Satoh AO, Horiuchi K, Fujioka M, Tsutsumi K, Sasaki J, Nepal P, Kashiwagi S, Paudel S, Nishide S, Nanbo A, Sasaki T, Ohba Y.

Cell Struct Funct. 2019 Apr 25;44(1):61-74. doi: 10.1247/csf.19001. Epub 2019 Mar 21.

18.

Alveolar soft part sarcoma metastatic to the breast: a case report.

Asano Y, Kashiwagi S, Takada K, Tokimasa S, Takashima T, Ohsawa M, Hirakawa K, Ohira M.

BMC Surg. 2019 Mar 4;19(1):30. doi: 10.1186/s12893-019-0494-8.

19.

Prognostic value of quality-of-life scores in patients with breast cancer undergoing preoperative chemotherapy.

Takada K, Kashiwagi S, Fukui Y, Goto W, Asano Y, Morisaki T, Takashima T, Hirakawa K, Ohira M.

BJS Open. 2018 Nov 26;3(1):38-47. doi: 10.1002/bjs5.50108. eCollection 2019 Feb.

20.

Mucosa-Associated Microbiota in the Gastrointestinal Tract of Healthy Japanese Subjects.

Kashiwagi S, Naito Y, Inoue R, Takagi T, Nakano T, Inada Y, Fukui A, Katada K, Mizushima K, Kamada K, Uchiyama K, Handa O, Ishikawa T, Itoh Y.

Digestion. 2019 Feb 5:1-14. doi: 10.1159/000496102. [Epub ahead of print]

PMID:
30721900
21.

[A Case of Breast Neuroendocrine Carcinoma].

Goto W, Kashiwagi S, Takada K, Asano Y, Morisaki T, Noda S, Takashima T, Onoda N, Hirakawa K, Ohira M.

Gan To Kagaku Ryoho. 2018 Dec;45(13):2432-2434. Japanese.

PMID:
30692488
22.

[A Case of a Malignant Phyllodes Tumor That Was Difficult to Distinguish from Stromal Sarcoma].

Goto W, Kashiwagi S, Takada K, Asano Y, Morisaki T, Noda S, Takashima T, Onoda N, Hirakawa K, Ohira M.

Gan To Kagaku Ryoho. 2018 Dec;45(13):2429-2431. Japanese.

PMID:
30692487
23.

[A Case of Multiple Lung Metastases from Breast Cancer Successfully Treated with Endocrine Therapy].

Goto W, Kashiwagi S, Takada K, Asano Y, Morisaki T, Noda S, Takashima T, Onoda N, Hirakawa K, Ohira M.

Gan To Kagaku Ryoho. 2018 Dec;45(13):2426-2428. Japanese.

PMID:
30692486
24.

[A Case of Apocrine Carcinoma in the Breast That Was Difficult to Distinguish from Axillary Apocrine Adenocarcinoma].

Mori T, Teraoka H, Kinoshita H, Hasegawa T, Noda E, Chikugo T, Kashiwagi S, Hirakawa K, Ohira M.

Gan To Kagaku Ryoho. 2018 Dec;45(13):1961-1963. Japanese.

PMID:
30692411
25.

[A Case of Male Breast Cancer Suspected of Breast Metastasis from Pancreatic Cancer].

Takada K, Kashiwagi S, Amano R, Goto W, Asano Y, Ohira G, Yamazoe S, Kimura K, Noda S, Takashima T, Onoda N, Hirakawa K, Ohira M.

Gan To Kagaku Ryoho. 2018 Dec;45(13):1857-1859. Japanese.

PMID:
30692377
26.

[A Case of Invasive Ductal Carcinoma with Paget's Disease of the Breast].

Asano Y, Kashiwagi S, Goto W, Takada K, Ishihara S, Tauchi Y, Morisaki T, Noda S, Takashima T, Onoda N, Hirakawa K, Ohira M.

Gan To Kagaku Ryoho. 2018 Dec;45(13):1842-1844. Japanese.

PMID:
30692372
27.

[A Case of Breast Cancer with Infarcted Necrosis That Was Diagnosed Based on Axillary Lymph Node Metastasis].

Kinoshita H, Teraoka H, Maekawa Y, Kitano M, Morikawa M, Sugita Y, Sakamoto A, Uono H, Mori T, Hasegawa T, Noda E, Chikugo T, Kashiwagi S, Hirakawa K, Ohira M.

Gan To Kagaku Ryoho. 2018 Dec;45(13):2217-2219. Japanese.

PMID:
30692336
28.

Impact of the occurrence of new lesions on the survival of patients who undergo chemotherapy for metastatic colorectal cancer.

Shibutani M, Maeda K, Nagahara H, Fukuoka T, Matsutani S, Kashiwagi S, Hirakawa K, Ohira M.

Mol Clin Oncol. 2019 Feb;10(2):285-292. doi: 10.3892/mco.2018.1778. Epub 2018 Nov 27.

29.

Clinical verification of the relationship between smoking and the immune microenvironment of breast cancer.

Takada K, Kashiwagi S, Asano Y, Goto W, Takahashi K, Fujita H, Takashima T, Tomita S, Hirakawa K, Ohira M.

J Transl Med. 2019 Jan 7;17(1):13. doi: 10.1186/s12967-019-1773-y.

30.

Effectiveness and safety of the pre-prescription of garenoxacin in comparison to moxifloxacin for low-risk febrile neutropenia in breast cancer patients undergoing adjuvant and neoadjuvant chemotherapy.

Takahashi M, Takahashi K, Ogawa K, Takashima T, Asano Y, Kashiwagi S, Noda S, Onoda N, Ohira M, Nagayama K.

Support Care Cancer. 2019 Aug;27(8):2829-2836. doi: 10.1007/s00520-018-4589-z. Epub 2018 Dec 13.

PMID:
30547304
31.

Tumor-infiltrating Immune Cells in H&E-stained Sections of Colorectal Cancer Tissue as a Reasonable Immunological Biomarker.

Matsutani S, Shibutani M, Maeda K, Nagahara H, Fukuoka T, Iseki Y, Kashiwagi S, Tanaka H, Hirakawa K, Ohira M.

Anticancer Res. 2018 Dec;38(12):6721-6727. doi: 10.21873/anticanres.13041.

PMID:
30504382
32.

Possibility of avoiding axillary lymph node dissection by immune microenvironment monitoring in preoperative chemotherapy for breast cancer.

Takada K, Kashiwagi S, Goto W, Asano Y, Takahashi K, Fujita H, Takashima T, Tomita S, Hirakawa K, Ohira M.

J Transl Med. 2018 Nov 19;16(1):318. doi: 10.1186/s12967-018-1692-3.

33.

Predictive value of lymphocyte-to-monocyte ratio in the preoperative setting for progression of patients with breast cancer.

Goto W, Kashiwagi S, Asano Y, Takada K, Takahashi K, Hatano T, Takashima T, Tomita S, Motomura H, Hirakawa K, Ohira M.

BMC Cancer. 2018 Nov 19;18(1):1137. doi: 10.1186/s12885-018-5051-9.

34.

Alkaline extracellular conditions promote the proliferation and mineralization of a human cementoblast cell line.

Muramatsu T, Kashiwagi S, Ishizuka H, Matsuura Y, Furusawa M, Kimura M, Shibukawa Y.

Int Endod J. 2019 May;52(5):639-645. doi: 10.1111/iej.13044. Epub 2018 Dec 11.

PMID:
30447154
35.

Brief Exposure of Skin to Near-Infrared Laser Modulates Mast Cell Function and Augments the Immune Response.

Kimizuka Y, Katagiri W, Locascio JJ, Shigeta A, Sasaki Y, Shibata M, Morse K, Sîrbulescu RF, Miyatake M, Reeves P, Suematsu M, Gelfand J, Brauns T, Poznansky MC, Tsukada K, Kashiwagi S.

J Immunol. 2018 Dec 15;201(12):3587-3603. doi: 10.4049/jimmunol.1701687. Epub 2018 Nov 12.

PMID:
30420435
36.

Significance of intrinsic breast cancer subtypes on the long-term prognosis after neoadjuvant chemotherapy.

Goto W, Kashiwagi S, Takada K, Asano Y, Takahashi K, Fujita H, Takashima T, Tomita S, Hirakawa K, Ohira M.

J Transl Med. 2018 Nov 9;16(1):307. doi: 10.1186/s12967-018-1679-0.

37.

Ginsenoside Rb1 promotes intestinal epithelial wound healing through extracellular signal-regulated kinase and Rho signaling.

Toyokawa Y, Takagi T, Uchiyama K, Mizushima K, Inoue K, Ushiroda C, Kashiwagi S, Nakano T, Hotta Y, Tanaka M, Dohi O, Okayama T, Yoshida N, Katada K, Kamada K, Ishikawa T, Handa O, Konishi H, Naito Y, Itoh Y.

J Gastroenterol Hepatol. 2019 Jul;34(7):1193-1200. doi: 10.1111/jgh.14532. Epub 2018 Nov 22.

PMID:
30394577
38.

Transforming growth factor β1-induced collagen production in myofibroblasts is mediated by reactive oxygen species derived from NADPH oxidase 4.

Hotta Y, Uchiyama K, Takagi T, Kashiwagi S, Nakano T, Mukai R, Toyokawa Y, Yasuda T, Ueda T, Suyama Y, Murakami T, Tanaka M, Majima A, Doi T, Hirai Y, Mizushima K, Morita M, Higashimura Y, Inoue K, Fukui A, Okayama T, Katada K, Kamada K, Handa O, Ishikawa T, Naito Y, Itoh Y.

Biochem Biophys Res Commun. 2018 Nov 30;506(3):557-562. doi: 10.1016/j.bbrc.2018.10.116. Epub 2018 Oct 23.

PMID:
30361098
39.

Predictive value of improvement in the immune tumour microenvironment in patients with breast cancer treated with neoadjuvant chemotherapy.

Goto W, Kashiwagi S, Asano Y, Takada K, Takahashi K, Hatano T, Takashima T, Tomita S, Motomura H, Ohsawa M, Hirakawa K, Ohira M.

ESMO Open. 2018 Aug 30;3(6):e000305. doi: 10.1136/esmoopen-2017-000305. eCollection 2018.

40.

A pilot clinical trial of a near-infrared laser vaccine adjuvant: safety, tolerability, and cutaneous immune cell trafficking.

Gelfand JA, Nazarian RM, Kashiwagi S, Brauns T, Martin B, Kimizuka Y, Korek S, Botvinick E, Elkins K, Thomas L, Locascio J, Parry B, Kelly KM, Poznansky MC.

FASEB J. 2019 Feb;33(2):3074-3081. doi: 10.1096/fj.201801095R. Epub 2018 Sep 7.

PMID:
30192655
41.

Correction to: Differences in gut microbiota associated with age, sex, and stool consistency in healthy Japanese subjects.

Takagi T, Naito Y, Inoue R, Kashiwagi S, Uchiyama K, Mizushima K, Tsuchiya S, Dohi O, Yoshida N, Kamada K, Ishikawa T, Handa O, Konishi H, Okuda K, Tsujimoto Y, Ohnogi H, Itoh Y.

J Gastroenterol. 2019 Jan;54(1):96-98. doi: 10.1007/s00535-018-1504-9.

PMID:
30191312
42.

Significance of re-biopsy for recurrent breast cancer in the immune tumour microenvironment.

Takada K, Kashiwagi S, Goto W, Asano Y, Takahashi K, Hatano T, Takashima T, Tomita S, Motomura H, Ohsawa M, Hirakawa K, Ohira M.

Br J Cancer. 2018 Aug;119(5):572-579. doi: 10.1038/s41416-018-0197-4. Epub 2018 Jul 23.

43.

Differences in gut microbiota associated with age, sex, and stool consistency in healthy Japanese subjects.

Takagi T, Naito Y, Inoue R, Kashiwagi S, Uchiyama K, Mizushima K, Tsuchiya S, Dohi O, Yoshida N, Kamada K, Ishikawa T, Handa O, Konishi H, Okuda K, Tsujimoto Y, Ohnogi H, Itoh Y.

J Gastroenterol. 2019 Jan;54(1):53-63. doi: 10.1007/s00535-018-1488-5. Epub 2018 Jun 20. Erratum in: J Gastroenterol. 2018 Sep 6;:.

PMID:
29926167
44.

Duration of fever and other symptoms after the inhalation of laninamivir octanoate hydrate in the 2016/17 Japanese influenza season; comparison with the 2011/12 to 2015/16 seasons.

Ikematsu H, Kawai N, Iwaki N, Kashiwagi S, Ishikawa Y, Yamaguchi H, Shiosakai K.

J Infect Chemother. 2018 Sep;24(9):718-724. doi: 10.1016/j.jiac.2018.04.013. Epub 2018 Jun 1.

45.

A Sialylated Voltage-Dependent Ca2+ Channel Binds Hemagglutinin and Mediates Influenza A Virus Entry into Mammalian Cells.

Fujioka Y, Nishide S, Ose T, Suzuki T, Kato I, Fukuhara H, Fujioka M, Horiuchi K, Satoh AO, Nepal P, Kashiwagi S, Wang J, Horiguchi M, Sato Y, Paudel S, Nanbo A, Miyazaki T, Hasegawa H, Maenaka K, Ohba Y.

Cell Host Microbe. 2018 Jun 13;23(6):809-818.e5. doi: 10.1016/j.chom.2018.04.015. Epub 2018 May 17.

46.

Novel evaluation scale for QOL (QOL-ACD-BP) in preoperative chemotherapy for breast cancer.

Takada K, Kashiwagi S, Goto W, Asano Y, Takahashi K, Morisaki T, Takashima T, Tomita S, Hirakawa K, Ohira M.

J Cancer Res Clin Oncol. 2018 Aug;144(8):1547-1559. doi: 10.1007/s00432-018-2670-0. Epub 2018 May 19.

47.

In vitro neuraminidase inhibitory concentration (IC50) of four neuraminidase inhibitors in the Japanese 2016-17 season: Comparison with the 2010-11 to 2015-16 seasons.

Ikematsu H, Kawai N, Iwaki N, Kashiwagi S, Ishikawa Y, Yamaguchi H, Shiosakai K.

J Infect Chemother. 2018 Sep;24(9):707-712. doi: 10.1016/j.jiac.2018.04.009. Epub 2018 May 11.

PMID:
29759897
48.

Eribulin Promotes Antitumor Immune Responses in Patients with Locally Advanced or Metastatic Breast Cancer.

Goto W, Kashiwagi S, Asano Y, Takada K, Morisaki T, Fujita H, Takashima T, Ohsawa M, Hirakawa K, Ohira M.

Anticancer Res. 2018 May;38(5):2929-2938.

PMID:
29715119
49.

A new method for evaluating tumor-infiltrating lymphocytes (TILs) in colorectal cancer using hematoxylin and eosin (H-E)-stained tumor sections.

Iseki Y, Shibutani M, Maeda K, Nagahara H, Fukuoka T, Matsutani S, Kashiwagi S, Tanaka H, Hirakawa K, Ohira M.

PLoS One. 2018 Apr 26;13(4):e0192744. doi: 10.1371/journal.pone.0192744. eCollection 2018.

50.

Clinical Significance of the Neutrophil-to-Lymphocyte Ratio in Endocrine Therapy for Stage IV Breast Cancer.

Iimori N, Kashiwagi S, Asano Y, Goto W, Takada K, Takahashi K, Hatano T, Takashima T, Tomita S, Motomura H, Hirakawa K, Ohira M.

In Vivo. 2018 May-Jun;32(3):669-675.

Supplemental Content

Loading ...
Support Center